We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TISI icon
901
Team
TISI
$80.6M
$99K ﹤0.01%
9,330
– –
ACCO icon
902
Acco Brands
ACCO
$399M
$93K ﹤0.01%
18,889
+6,104
+48% +$38.6K
NGNE icon
903
Neurogene
NGNE
$672M
$93K ﹤0.01%
7,270
– –
LRMR icon
904
Larimar Therapeutics
LRMR
$377M
$90K ﹤0.01%
28,064
– –
ATTO
905
DELISTED
Atento S.A.
ATTO
$88K ﹤0.01%
21,742
– –
NMRK icon
906
Newmark Group
NMRK
$2.64B
$86K ﹤0.01%
+10,634
New +$110K
WW
907
DELISTED
WW International
WW
$85K ﹤0.01%
21,744
-15,945
-42% -$96.6K
OPFI icon
908
OppFi
OPFI
$813M
$82K ﹤0.01%
+35,779
New +$102K
CNVS icon
909
Cineverse
CNVS
$56.9M
$79K ﹤0.01%
10,000
– –
OSCR icon
910
Oscar Health
OSCR
$9.22B
$79K ﹤0.01%
+15,889
New +$92.7K
RNWK
911
DELISTED
RealNetworks Inc
RNWK
$70K ﹤0.01%
100,171
– –
OPRT icon
912
Oportun Financial
OPRT
$262M
$66K ﹤0.01%
+15,125
New +$108K
GHL
913
DELISTED
Greenhill & Co., Inc.
GHL
$64K ﹤0.01%
10,788
-8,786
-45% -$69.2K
TEAD
914
Teads Holding Co
TEAD
$76.2M
$60K ﹤0.01%
16,509
+6,010
+57% +$29.2K
RPID icon
915
Rapid Micro Biosystems
RPID
$102M
$58K ﹤0.01%
+17,900
New +$69.5K
MYPS icon
916
PLAYSTUDIOS Inc
MYPS
$76.2M
$56K ﹤0.01%
+16,095
New +$61.3K
LYLT
917
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$55K ﹤0.01%
45,197
– –
ORGO icon
918
Organogenesis Holdings
ORGO
$324M
$54K ﹤0.01%
+16,686
New +$75.4K
PHGE icon
919
BiomX
PHGE
$1.97M
$54K ﹤0.01%
835
-895
-52% -$114K
SPIR icon
920
Spire Global
SPIR
$408M
$54K ﹤0.01%
6,250
– –
ASPU
921
DELISTED
ASPEN GROUP, INC.
ASPU
$54K ﹤0.01%
141,520
– –
RMNI icon
922
Rimini Street
RMNI
$457M
$52K ﹤0.01%
+11,234
New +$63K
CEMI
923
DELISTED
Chembio diagnostics, Inc.
CEMI
$49K ﹤0.01%
135,800
– –
CURV icon
924
Torrid Holdings
CURV
$274M
$43K ﹤0.01%
+10,410
New +$54.5K
AGEN
925
Agenus
AGEN
$276M
$30K ﹤0.01%
746
-474
-39% -$24.2K
35 36
37
38 39

Similar funds

GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return
LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $9.98B AUM 4.97% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.